- By insider
Chairman & CEO of Edwards Lifesciences Corp (EW) Michael A Mussallem sold 49,100 shares of EW on 07/28/2016 at an average price of $113.31 a share. The total sale was $5.6 million.
Edwards Lifesciences Corp technologies that treat structural heart disease and critically ill patients. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $24.19 billion; its shares were traded at around $114.23 with a P/E ratio of 47.50 and P/S ratio of 9.69. Edwards Lifesciences Corp had an annual average EBITDA growth of 19.10% over the past 10 years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star.
-
Warning! GuruFocus has detected 3 Warning Sign with AAPL. Click here to check it out.
-
The intrinsic value of EW
CEO Recent Trades:
-
Chairman & CEO Michael A Mussallem sold 49,100 shares of EW stock on 07/28/2016 at the average price of $113.31. The price of the stock has increased by 0.81% since.
Directors and Officers Recent Trades:
-
CVP, Europe Patrick B Verguet sold 10,000 shares of EW stock on 07/29/2016 at the average price of $114.87. The price of the stock has decreased by 0.56% since.
-
VP, Corporate Controller Robert W.a. Sellers sold 10,000 shares of EW stock on 07/29/2016 at the average price of $114.33. The price of the stock has decreased by 0.09% since.
-
CVP, Japan & Intercontinental Huimin Wang sold 13,650 shares of EW stock on 07/05/2016 at the average price of $98.44. The price of the stock has increased by 16.04% since.
For the complete insider trading history of EW, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 3 Warning Sign with AAPL. Click here to check it out.
-
The intrinsic value of EW